|
|
EQSNews: Unicycive Therapeautics, Inc.
Planned Government Move To Expand Access To Drugs For EndStage Renal Disease Patients Could Shine The Spotlight On Unicycive
08.12.2022 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
In the U.S., reimbursement of dialysis expenses by the Centers... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Unicycive Therapeautics, Inc.
Unicycive’s Doug Jermasek, EVPCorporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden
08.11.2022 / 15:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Unicycive Therapeautics, Inc.
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
12.10.2022 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
You may remember learning that mitochondria are the powerhouse of... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Unicycive Therapeautics, Inc.
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
23.09.2022 / 15:12 CET/CEST
The issuer is solely responsible for the content of this announcement.
Most people are surprised to learn that chronic kidney disease CKD is the fastest g... Lire le communiqué |
|
| |
|
| |
